DiveRadGel Co., Ltd.

Our mission is to create groundbreaking cancer immunotherapies that offer hope for curing refractory cancers, and ultimately reduce the suffering of cancer patients. At the core of our development pipeline is a cancer vaccine utilizing Sonanos™, a hyaluronic acid nanogel with immune cell-targeting capabilities. Furthermore, we are advancing the development of a combination therapy with Sonanos™ cancer vaccine and genetically engineered T-cell therapy, offering potential for remission and prevention of recurrence in refractory cancers.